Osteopenia in HIV Positive Patients After 8 Months on Tenofovir: A Case Study
Karra Geetha, R. Sakshi, T. Chandana, Ch. Sai Chandu & T. Ramarao · Asian Journal of Advanced Research and Reports · 2024
Tenofovir, a nucleotide reverse transcriptase inhibitor, is a key component of highly active antiretroviral therapy (HAART) for HIV infection. While effective in suppressing viral replication, long-term use of tenofovir has been associated with adverse effects, including bone min...
Open access
Research Article
10.9734/ajarr/2024/v18i7681